Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer
Authors:
- 1 February 1986
- journal article
- clinical trial
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 31 (S2) , 63S-67S
Abstract
This study was undertaken to evaluate the efficacy of misoprostol taken twice daily for the healing of duodenal ulcer. Three hundred thirty patients with endoscopically proven duodenal ulcer participated in a multicenter, double-blind, controlled trial comparing placebo with misoprostol 200 μg and 400 μg twice daily for up to four weeks. Patient characteristics were similar in all three treatment groups. Ulcers were between 0.3 cm and 2.0 cm in length. Healing was determined by endoscopy at two weeks; if ulcers were not healed, endoscopy was repeated at four weeks. All patients were given Al(OH)3 antacid (up to 54 meq a day) to be used as needed for pain. Healing rates at four weeks for a total of 280 evaluable patients in the three treatment groups were as follows: misoprostol 400 μg bid, 65.4%; misoprostol 200 μg bid, 52.9%; and placebo, 42.2%. Misoprostol 400 μg bid was superior to placebo (P=0.002) in healing ulcers. However, the healing rate for misoprostol 200 μg bid did not differ significantly from placebo. The percentage of nonsmokers who healed at four weeks was higher than that of smokers in both misoprostoltreatment groups, although the difference was not analyzed for statistical significance. There were no differences in antacid consumption or pain relief among the three experimental groups during the study. Diarrhea was the most common side effect but was mild and self-limiting, occurring in 8.9%, 5.9%, and 1.8% of the misoprostol 400 μg, 200 μg, and placebo groups, respectively. These results indicate that misoprostol 400 μg, 200 μg, and for four weeks is effective and safe for the treatment of duodenal ulcers.Keywords
This publication has 30 references indexed in Scilit:
- Misoprostol in the treatment of duodenal ulcerDigestive Diseases and Sciences, 1985
- Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcersDigestive Diseases and Sciences, 1985
- Cimetidine, Cigarette Smoking, and Recurrence of Duodenal UlcerNew England Journal of Medicine, 1984
- Ranitidine in duodenal ulcerDigestive Diseases and Sciences, 1982
- Cimetidine and ranitidine in duodenal ulcer.BMJ, 1980
- Endogenous prostaglandins in peptic ulcer disease.Gut, 1979
- Healing of Duodenal Ulcer with an Antacid RegimenNew England Journal of Medicine, 1977
- SC-29333: A potent inhibitor of canine gastric secretionDigestive Diseases and Sciences, 1976
- Screening Effects in Multidimensional Contingency TablesJournal of the Royal Statistical Society Series C: Applied Statistics, 1976
- Prostaglandin E in peptic ulcer diseaseProstaglandins, 1974